Breaking News: Bionomics Limited Sets Price for American Depositary Shares in the US!
Welcome to the Bionomics Blog! 🚀 Exciting News From Bionomics Limited! ADELAIDE, Australia, Nov. 16, 2022 (GLOBE NEWSWIRE) — Bionomics Limited (ASX: BNO, Nasdaq: BNOX), (“Bionomics” or the “Company”), a clinical-stage biopharmaceutical company developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (“CNS”) disorders with…